TherapeuticsMD, Inc. (NYSE MKT: TXMD) announced today that it will
present at the Stifel Nicolaus 2013 Healthcare Conference to be held
September 11-12, 2013 at the Four Seasons Hotel Boston.
Robert Finizio, Co-Founder and Chief Executive Officer, will present on
Thursday, September 12, 2013 at 3:50 p.m. EDT.
The presentation will also be available via a live audio webcast at the
following link: http://www.veracast.com/webcasts/stifel/healthcare2013/61213535118.cfm
Following the presentation, a replay will be available through
TherapeuticsMD’s website at www.therapeuticsmd.com
under the "Investor Relations" section and will remain available for 30
days after the actual presentation date.
About TherapeuticsMD, Inc.
TherapeuticsMD, Inc. is a women’s healthcare company focused on
developing and commercializing products targeted exclusively for women.
We manufacture and distribute branded and generic prescription prenatal
vitamins, as well as over-the-counter vitamins and cosmetics, under our
vitaMedMD® and BocaGreenMD™ brands. We are currently
developing advanced hormone therapy pharmaceutical products designed to
alleviate the symptoms of and reduce the health risks resulting from
menopause-related hormone deficiencies. We are also evaluating various
other potential indications for our hormone technology, including oral
contraception, preterm birth, vulvar and vaginal atrophy, and premature
ovarian failure. More information is available at the following
websites: www.therapeuticsmd.com,
www.vitamedmd.com,
www.vitamedmdrx.com,
and www.bocagreenmd.com.
vitaMedMD® is a registered trademark and TherapeuticsMD®
and BocaGreenMD™ are trademarks of TherapeuticsMD, Inc.
Copyright Business Wire 2013